Sarah Wild

Medicine & Life Sciences

1. Scotland 100%
2. Type 2 Diabetes Mellitus 99%
3. Genome-Wide Association Study 65%
4. Population 47%
5. Cohort Studies 43%
6. Mortality 41%
7. Genome 41%
8. Meta-Analysis 38%
9. Cardiovascular Diseases 37%
10. Type 1 Diabetes Mellitus 36%
11. Non-alcoholic Fatty Liver Disease 32%
12. Fatty Liver 27%
13. Obesity 26%
14. Body Mass Index 24%
15. Incidence 23%
16. Genes 23%
17. Single Nucleotide Polymorphism 22%
18. Blood Pressure 22%
19. England 20%
20. Retrospective Studies 19%
21. Glucose 19%
22. Insulin Resistance 19%
23. Social Class 19%
24. Chronic Obstructive Pulmonary Disease 17%
25. Systematic Reviews 16%
26. Confidence Intervals 16%
27. Fasting 16%
28. Metabolic Syndrome 15%
29. Uric Acid 14%
30. Adiposity 14%
31. Randomized Controlled Trials 14%
32. Serum 13%
33. Observational Studies 13%
34. Diabetes Mellitus 13%
35. Insulin 13%
36. Coronary Vessels 13%
37. Lipids 13%
38. Genetic Loci 12%
39. Calcium 12%
40. Wales 12%
41. Epidemiology 12%
42. Income 12%
43. Health 12%
44. Kidney 12%
45. Weights and Measures 12%
46. Genetic Association Studies 11%
47. Hydroxymethylglutaryl-CoA Reductase Inhibitors 11%
48. Costs and Cost Analysis 11%
49. Neoplasms 11%
50. Smoking 11%